-
Australia's Khawaja announces retirement from international cricket
-
Niners seek win for home-field playoff edge into Super Bowl
-
New York mayor Mamdani pledges left-wing success after taking office
-
Slot frustrated by blunt Liverpool in Leeds stalemate
-
Toothless Liverpool held by Leeds
-
Dozens killed as fire ravages Swiss ski resort New Year party
-
K-pop stars BTS to release album in March ahead of world tour
-
Fresh clashes kill six in Iran cost-of-living protests
-
Nigeria kicks off new tax regime vowing relief for low earners
-
Dozens killed in fire at Swiss ski resort New Year party
-
Leftist Mamdani begins first day as New York mayor
-
Dozens believed killed in fire at Swiss ski resort New Year party
-
Brazil Supreme Court rejects Bolsonaro request for house arrest on health concerns
-
Israel confirms ban on 37 NGOs in Gaza
-
Russia blames Ukraine for deadly New Year drone strike
-
Coach Maresca leaves Chelsea - club
-
'Several dozen' believed killed in fire at Swiss ski resort New Year party
-
China's BYD logs record EV sales in 2025
-
Yemen separatists say Saudi-backed forces to deploy in seized territories
-
Wales rugby star Rees-Zammit signs long-term deal to stay at Bristol
-
'Several dozen' believed killed in fire at Swiss ski resort New Year bash
-
Hakimi, Salah and Osimhen head star-packed AFCON last-16 cast
-
Israel says it 'will enforce' ban on 37 NGOs in Gaza
-
Near record number of small boat migrants reach UK in 2025
-
Several dead as fire ravages bar in Swiss ski resort town Crans Montana: police
-
Tsitsipas considered quitting tennis during injury-hit 2025
-
Sabalenka wants 'Battle of the Sexes' rematch and revenge
-
Osaka drawing inspiration from family at United Cup
-
Leftist Mamdani takes over as New York mayor under Trump shadow
-
Israel's Netanyahu among partygoers at Trump's New Year's Eve fete
-
Champagnie, Wemby lead Spurs comeback in Knicks thriller
-
Eight dead in US strikes on alleged drug boats: US military
-
Trump joins criticism of Clooney's French passport
-
AI, chips boom sent South Korea exports soaring in 2025
-
Taiwan's president vows to defend sovereignty after China drills
-
N. Korea's Kim hails 'invincible alliance' with Russia in New Year's letter
-
In Venezuela, price of US dollar up 479 percent in a year
-
Cummins, Hazlewood in spin-heavy Australia squad for T20 World Cup
-
Ex-boxing champ Joshua discharged from hospital after fatal car crash
-
Kamenar to Open for Tom Hamilton of Aerosmith's New Band Close Enemies at the World-Famous Whisky a Go Go - January 3, 2026
-
SUPCASE Unveils Its 2026 Brand Evolution: Lighter in Form, Stronger in Purpose
-
The EPOMAKER RT82: Where Retro Meets Modern Technology
-
Zelensky says deal to end war '10 percent' away
-
Trump bashes Clooney after actor becomes French
-
We are '10 percent' away from peace, Zelensky tells Ukrainians
-
Trump says pulling National Guard from three cities -- for now
-
Ivory Coast top AFCON group ahead of Cameroon, Algeria win again
-
World welcomes 2026 after a year of Trump, truces and turmoil
-
Ivory Coast fight back to pip Cameroon for top spot in AFCON group
-
Second Patriots player facing assault charge
| SCS | 0.12% | 16.14 | $ | |
| NGG | -0.54% | 77.35 | $ | |
| BCC | -0.26% | 73.6 | $ | |
| RBGPF | -0.37% | 80.75 | $ | |
| BTI | 0.12% | 56.62 | $ | |
| CMSC | -0.15% | 22.65 | $ | |
| AZN | -0.63% | 91.93 | $ | |
| RIO | -0.61% | 80.03 | $ | |
| CMSD | 0.09% | 23.15 | $ | |
| BCE | 1.05% | 23.82 | $ | |
| GSK | -0.53% | 49.04 | $ | |
| JRI | 0.22% | 13.61 | $ | |
| RELX | -1.71% | 40.42 | $ | |
| RYCEF | 0.13% | 15.51 | $ | |
| VOD | -0.15% | 13.21 | $ | |
| BP | -0.06% | 34.73 | $ |
Appetite-regulating hormones in focus as first Nobel Prizes fall
Research into hormones that regulate appetite is seen leading the race for the Nobel Prize in Medicine, to be awarded Monday -- the first in this year's Nobel season.
At a time when more than one billion people suffer from obesity, research into the hormone called "glucagon-like peptide 1" (GLP-1) could be given the nod for the Nobel Prize in Physiology or Medicine this year, experts said.
A new generation of drugs using GLP-1 agonists -- including blockbuster brands Ozempic, Wegovy and Mounjaro -- has provided a valuable tool to fight obesity and diabetes globally.
"Many are guessing that it (the Nobel Prize in Medicine) will go to the people behind GLP-1," Lars Brostrom, science editor at public broadcaster Sveriges Radio, told AFP.
That could help researchers from major US institutions once again dominate the Nobel Prizes in sciences, which are to be announced this week in Stockholm.
But, even if that happens, US politics is to cast a shadow over them, given budget cuts to science programmes ordered by President Donald Trump's government.
Since January, the US National Institutes of Health (NIH) has terminated 2,100 research grants totalling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch.
Such cuts could fuel debate over the growing risk that the United States could lose its edge in scientific research.
"In the post-war period, the US has taken over Germany's role as the world's leading scientific nation," Hans Ellegren, secretary general of the Royal Swedish Academy of Sciences, which awards Nobel Prizes in physics, chemistry, and economics, told AFP.
"When they now start cutting research funding, it threatens the country's position."
- Many contenders -
When it comes to GLP-1, as with many other discoveries, it can be hard to narrow down who exactly deserves to be honoured when many scientists around the world have made significant contributions.
Brostrom said some names often speculated upon are Danish physician Jens Juul Holst, and Joel Habener, a professor of medicine at Harvard, as well as Canadian endocrinologist Daniel Drucker and Yugoslav-born American chemist Svetlana Mojsov.
Despite treatments such as Ozempic being recently introduced, and the Nobel Assembly at the Karolinska Institute more often honouring discoveries that are decades old, "it could also be perfect timing" for GLP-1 recognition "because the discovery itself was made back in the 80s", Brostrom said.
In the same field, research on ghrelin, a hormone that stimulates appetite, could earn a Nobel Prize for two Japanese researchers, Kenji Kangawa and Masayasu Kojima, according to David Pendlebury, who heads research analysis at the firm Clarivate -- which predicts potential Nobel winners based on the number of citations of their work.
Pendlebury said that would also form "a nice bookend to a 1994 discovery" by geneticist Jeffrey Friedman, who discovered another appetite-regulating hormone, leptin, and who has previously been spotlighted by Clarivate.
"We have a combination of very nice discoveries, a hormone for appetite, a hormone that suppresses appetite, and this may also play into a lot of speculation of a prize for the GLP-1," he told AFP.
Clarivate also said the work of German medical professor Andrea Ablasser, American virologist Glen N. Barber, and Chinese-American biochemist Zhijian "James" Chen could be honoured "for elucidating the cGAS-STING pathway, a fundamental mechanism of innate immunity".
It noted that Canadian biologist John E. Dick could also be a contender "for identifying leukaemia stem cells and establishing their relevance in therapy failure".
- 'Invisibility cloak' -
For the Nobel Prize in Physics on Tuesday, experts at Sweden's public radio cited research into metamaterials, which has been buzzed about for several years.
British physicist John B. Pendry has in particular been frequently mentioned for his "invisibility cloak" -- a theoretical method to redirect electromagnetic fields around an object.
The Nobel season continues Wednesday with the prize for chemistry, followed on Thursday by the closely watched literature prize and on Friday the peace prize, which Donald Trump has argued should go to him.
The economics prize wraps up the Nobel season on October 13.
In addition to each honour, the prize includes a diploma, a gold medal, and a check for 11 million Swedish kronor ($1.2 million).
J.Williams--AMWN